Abstract
Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.
Ivan Foeldvari, Susanne Nielsen, Jasmin Kümmerle-Deschner, Graciela Espada, Gerd Horneff, Blanca Bica, Alma N Olivieri, Angela Wierk and Rotraud K Saurenmann
The Journal of Rheumatology May 2007, 34 (5) 1146-1150;
Ivan Foeldvari
Susanne Nielsen
Jasmin Kümmerle-Deschner
Graciela Espada
Gerd Horneff
Blanca Bica
Alma N Olivieri
Angela Wierk
In this issue
The Journal of Rheumatology
Vol. 34, Issue 5
1 May 2007
Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.
Ivan Foeldvari, Susanne Nielsen, Jasmin Kümmerle-Deschner, Graciela Espada, Gerd Horneff, Blanca Bica, Alma N Olivieri, Angela Wierk, Rotraud K Saurenmann
The Journal of Rheumatology May 2007, 34 (5) 1146-1150;
Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.
Ivan Foeldvari, Susanne Nielsen, Jasmin Kümmerle-Deschner, Graciela Espada, Gerd Horneff, Blanca Bica, Alma N Olivieri, Angela Wierk, Rotraud K Saurenmann
The Journal of Rheumatology May 2007, 34 (5) 1146-1150;